A study following more than 4,000 nurses in the United States has found that breast cancer survivors who consumed aspirin regularly were half as likely to die or have the cancer return, Reuters reports.
According to the study, which was published this week in the Journal of Clinical Oncology, women who took aspirin regularly after surviving breast cancer were 50 percent less likely of dying or having the cancer return as those who did not. The study followed over 4,000 female registered nurses in the United States taking park in the Nurses’ Health Study.
The study presents the theory that a return of breast cancer, which produces more inflammatory chemicals than regular breast cells, is prevented by aspirin because it prevents breast tumor cells from growing, USA Today reports.
“This is the first study to find that aspirin can significantly reduce the risk of cancer spread and death for women who have been treated for early stage breast cancer,” Dr. Michelle Holmes of Harvard Medical School, who led the study, said.
“If these findings are confirmed in other clinical trials, taking aspirin may become another simple, low-cost and relatively safe tool to help women with breast cancer live longer, healthier lives.”
While the study sounds promising, doctors are warning that it is too soon to determine whether women should start taking aspirin when they are first diagnosed with breast cancer, but claim the study results merit further research.
Find out more about breast cancer.
Image: http://commons.wikimedia.org/wiki/File:Mamograf%C3%ADa_BIRADs_IV.jpgTags: breast cancer cancer study